En coup de sabre accompanied by pachydermoperiostosis: A case report

Clinical and Experimental Rheumatology

Volumn 25, Issue 2, 2007, Pages 315-317

  Özdemir, Mustafa ^a   Yildirim, Selman ^a   Mevlitoǧlu, Inci ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

En coup de sabre; Human fibrosis; Pachydermoperiostosis

Indexed keywords

4 AMINOBENZOATE POTASSIUM; ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; COLCHICINE; GROWTH HORMONE; PENICILLIN G; RHEUMATOID FACTOR; STEROID;

ADULT; ALOPECIA; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CLUBFOOT; CONSANGUINEOUS MARRIAGE; ELECTROCARDIOGRAM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERHIDROSIS; HYPERTROPHIC SKIN DISEASE; INTRAUTERINE GROWTH RETARDATION; LIMB SWELLING; LINEAR SCLERODERMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PACHYDERMOPERIOSTOSIS; PRIORITY JOURNAL; SKIN ATROPHY; SKIN BIOPSY; SKULL DEFECT; THORAX RADIOGRAPHY;

ADULT; ATROPHY; BONE AND BONES; FEMALE; HUMANS; OSTEOARTHROPATHY, PRIMARY HYPERTROPHIC; OSTEOARTHROPATHY, SECONDARY HYPERTROPHIC; SCLERODERMA, LOCALIZED; SKIN;

EID: 34249823686     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. SEHGAL VN, SRIVASTAVA G, BAJAJ P: En coup de sabre. Int J Dermatol 2002; 41: 504-5.
2. GAMBICHLER T, KREUTER A, HOFFMANN K, BECHARA FG, ALTMEYER P, JANSEN T: Bilateral linear scleroderma "en coup de sabre" associated with facial atrophy and neurological complications. BMC Dermatol 2001; 1: 9.
3. ZARAFONETIS CJ, DABICH L, SKOVRONSKI et al.: Retrospective studies in scleroderma: Skin response to potassium para-aminobenzoate therapy. Clin Exp Rheumatol 1988; 6: 261-8.
4. KATZ KA: Frontal linear scleroderma (en coup de sabre). Dermatol Online J 2003; 9: 10.
5. STONE J, FRANKS AJ, GUTHRIE JA, JOHNSON MH: Scleroderma "en coup de sabre": Pathological evidence of intracerebral inflammation. J Neurol Neurosurg Psychiatry 2001; 70: 382-5.
6. MARZANO AV, MENI S, PARODI A et al.: Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 2003; 13: 171-6.
7. YU BD, EISEN AZ: Scleroderma. In FREED- BERG IM, EISEN AZ, WOLFF K, AUSTEN KF, GOLDSMITH LA, KATZ SI, eds: Fitzpatrick's dermatology in general medicine. New York, McGraw-Hill 2003; 1709-1718.
8. IKEDA F, OKADA H, MIZUNO M et al.: Pachydermoperiostosis associated with juvenile polyps of the stomach and gastric adenocarcinoma. J Gasrtoenterol 2004; 39: 370-4.
9. JAJIC Z, JAJIC I, NEMCIC T: Primary hypertrophic osteoarthtopathy: clinical, radiologic, and scintigraphic characteristics. Arch Med Res 2001; 32: 136-42.
10. KAHALEH MB: The role of vascular endothelium in fibroblast activaiton and tissue fibrosis, particularly in sckeroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteo-arthropathy). Clin Exp Rheumatol 1992; 10 (Suppl. 7): 51-6.
11. PADULA SJ, BROKETA G, SAMPIERI et al.: Increased collagen synthesis in skin fibroblasts from patients with primary hypertrophic osteoarthropathy. Arthritis Rheum 1994; 37: 1386-94.
12. MATUCCI-CERINIC M, PIGNONE A, GENERINI S et al.: Can fibroblasts determine the late differing outcome between systemic sclerosis and primary hypertrophic osteoarthropathy (pachydermoperiostosis)? Clin Exp Rheumatol 2000; 18: 1-2.